Delivery Order SPE2DB20D3103-SPE2DB25FN5D9
Award Date
4/21/25
Potential Completion Date
4/22/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $6,798.50, is for the delivery of 4,563,575,086 units of the pharmaceutical product Repaglinide 1 mg Tablet in 100-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of February 7, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
This federal contract award, identified as SPE2DB24D1034|SPE2DB25FWAQ2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567321287 units of 1 mg Repaglinide tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,628.82 and a period of performance through February 21, 2025. This award...
This federal contract award, with ID SPE2DB22D1017 and SPE2DB25FF6GE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,940.04 firm fixed-price delivery order is for 4567378518 - REPAGLINIDE 2 MG TABLET 100S, and has a completion date of February 26, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $12,650.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order for the supply of Repaglinide 1 mg tablets, which are used to treat diabetes. The contract has an Ultimate Completion Date of February 5, 2024 and was awarded on February 2, 2024 under a Firm Fixed Price pricing type. This contract award is not designated with any set-aside...
This federal contract award is for the delivery of Repaglinide 1 mg tablets to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $7,964.57, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 1, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Repaglinide 1 mg tablets, a medication used to manage diabetes, with a ceiling value of $13,095.99 and a period of performance through May 6, 2024. The contract was awarded as a Firm Fixed Price Delivery Order and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
The federal contract award is for the delivery of 100 tablets of the pharmaceutical drug Repaglinide 1 mg. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $1,609.80 and a period of performance through February 5, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
Amerisourcebergen Drug Corp has been awarded a $188 firm fixed price delivery order against an unidentified contract vehicle to supply 100 tablets of 1 mg repaglinide to the Defense Logistics Agency. Performance will take place in Conshohocken, Pennsylvania by October 13, 2023. No set-aside provisions were applied to this order. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will fulfill the order for the repaglinide tablets on behalf of the Defense Logistics Agency to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,675.22 firm-fixed-price delivery order is for the supply of 4,566,177,969 units of the medication Nateglinide 120 mg Tablet UD 30s. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,181.48 firm-fixed-price delivery order is for the supply of 4,568,061,670 units of the prescription medication Nateglinide 120 mg tablets. The contract has an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award....